NCT05990569

Brief Summary

Study Description: The goal of this clinical trial is to compare the duration of postoperative pain relief achieved with two different approaches to pudendal nerve block in patients undergoing elective perianal surgery. The main question this study aims to answer is whether adding Methylene Blue to Bupivacaine pudendal nerve block can prolong postoperative analgesia compared to using Bupivacaine alone. Participants in this study will be individuals with ASA I and II physical status undergoing elective perianal surgery under spinal anesthesia. They will be randomly assigned to one of two groups:

  1. 1.Group A (Case Group): Participants will receive a pudendal nerve block with Bupivacaine combined with Methylene Blue.
  2. 2.Group B (Control Group): Participants will receive a pudendal nerve block with Bupivacaine alone.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 28, 2023

Completed
15 days until next milestone

Study Start

First participant enrolled

August 12, 2023

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 14, 2023

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2024

Completed
Last Updated

November 9, 2023

Status Verified

November 1, 2023

Enrollment Period

10 months

First QC Date

July 28, 2023

Last Update Submit

November 8, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Time to the first rescue analgesic administration (in minutes) in the two study groups

    We will compare the time at which patients in either group will demand rescue analgesic

    48 hours

  • Patient satisfaction assessed using the Likert scale after receiving Bupivacaine pudendal nerve block with or without Methylene Blue.

    We will ask the patient to select one of the following satisfaction scores: Very satisfied Moderately satisfied Neither satisfied nor dissatisfied Moderately dissatisfied Very dissatisfied

    Seven days

Secondary Outcomes (2)

  • Numeric Rating Scale (NRS) score for pain intensity at different time intervals

    Seven days

  • Complications

    seven days

Study Arms (2)

Arm A

EXPERIMENTAL

Bupivacaine

Other: Ultrasound guided Pudendal nerve block

Arm B

EXPERIMENTAL

Bupivacaine with methylene blue

Other: Ultrasound guided Pudendal nerve block

Interventions

Ultrasound guided bilateral pudendal nerve block

Arm AArm B

Eligibility Criteria

Age15 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • All patients of ASA I and II undergoing elective perianal surgery under spinal anesthesia

You may not qualify if:

  • Patient's refusal
  • Patient with a history of allergy to the local anesthetic or Methylene blue
  • Bleeding diathesis or coagulopathy
  • Extensive infection at the site of injection
  • Pregnancy and lactating mother
  • Spinal abnormality
  • Patients with neurological deficit

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nepal Mediciti Hospital

Lalitpur, 44700, Nepal

RECRUITING

Related Publications (10)

  • Imbelloni LE, Vieira EM, Gouveia MA, Netinho JG, Spirandelli LD, Cordeiro JA. Pudendal block with bupivacaine for postoperative pain relief. Dis Colon Rectum. 2007 Oct;50(10):1656-61. doi: 10.1007/s10350-007-0216-7.

    PMID: 17701375BACKGROUND
  • Sim HL, Tan KY. Randomized single-blind clinical trial of intradermal methylene blue on pain reduction after open diathermy haemorrhoidectomy. Colorectal Dis. 2014 Aug;16(8):O283-7. doi: 10.1111/codi.12587.

    PMID: 24506265BACKGROUND
  • Naja Z, Ziade MF, Lonnqvist PA. Nerve stimulator guided pudendal nerve block decreases posthemorrhoidectomy pain. Can J Anaesth. 2005 Jan;52(1):62-8. doi: 10.1007/BF03018582.

    PMID: 15625258BACKGROUND
  • Kunitake H, Poylin V. Complications Following Anorectal Surgery. Clin Colon Rectal Surg. 2016 Mar;29(1):14-21. doi: 10.1055/s-0035-1568145.

    PMID: 26929747BACKGROUND
  • Ceulemans A, De Looze D, Van de Putte D, Stiers E, Coppens M. High post-operative pain scores despite multimodal analgesia in ambulatory anorectal surgery: a prospective cohort study. Acta Chir Belg. 2019 Aug;119(4):224-230. doi: 10.1080/00015458.2018.1500802. Epub 2018 Sep 7.

    PMID: 30189793BACKGROUND
  • Garimella V, Cellini C. Postoperative pain control. Clin Colon Rectal Surg. 2013 Sep;26(3):191-6. doi: 10.1055/s-0033-1351138.

    PMID: 24436674BACKGROUND
  • Abdi S, Shenouda P, Patel N, Saini B, Bharat Y, Calvillo O. A novel technique for pudendal nerve block. Pain Physician. 2004 Jul;7(3):319-22.

    PMID: 16858468BACKGROUND
  • Ginimuge PR, Jyothi SD. Methylene blue: revisited. J Anaesthesiol Clin Pharmacol. 2010 Oct;26(4):517-20. No abstract available.

    PMID: 21547182BACKGROUND
  • Lee SW, Han HC. Methylene Blue Application to Lessen Pain: Its Analgesic Effect and Mechanism. Front Neurosci. 2021 May 17;15:663650. doi: 10.3389/fnins.2021.663650. eCollection 2021.

    PMID: 34079436BACKGROUND
  • Steen CJ, Lam D, Chandra R, Chua JYJ, An V, Keck JO. Pudendal Nerve Block for Posthemorrhoidectomy Pain: A Prospective, Single-Blinded Randomized Control Trial. Dis Colon Rectum. 2022 Apr 1;65(4):546-551. doi: 10.1097/DCR.0000000000002293.

    PMID: 34759239BACKGROUND

MeSH Terms

Conditions

HemorrhoidsFissure in AnoFistulaPilonidal Sinus

Condition Hierarchy (Ancestors)

Rectal DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System DiseasesVascular DiseasesCardiovascular DiseasesAnus DiseasesPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsCystsNeoplasms

Study Officials

  • Pragati Koirala, MD

    Nepal Mediciti

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident Doctor

Study Record Dates

First Submitted

July 28, 2023

First Posted

August 14, 2023

Study Start

August 12, 2023

Primary Completion

June 1, 2024

Study Completion

July 1, 2024

Last Updated

November 9, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations